If youve been working hard to shed stubborn body fat but feel like your progress has plateaued, it might be time to look beyond the basics
Recent Changes in Compounding Pharmacies In line with the latest FDA guidelines, many compounding pharmacies are reevaluating the formulations they provide
The market growth is driven by drugs with increasing potency to induce weight loss, more convenient oral formulations that help drive adoption as well as increasing interest from non-obese patients looking for weight loss alternatives to diet & exercise
And while many people say the trade-off is worth it, the unexpected hit to their identity and social lives can be tough to swallow
What the Evidence Shows The clinical trial data for GLP-1 medications is among the strongest ever produced for a non-surgical weight loss intervention: Ozempic (semaglutide 12mg): Mean weight loss of approximately 1012% of body weight over 4068 weeks in SUSTAIN trials Wegovy (semaglutide 2.4mg): Mean weight loss of 1517% of body weight over 68 weeks in STEP trials Mounjaro (tirzepatide 15mg): Mean weight loss of 2022% of body weight over 72 weeks in SURMOUNT trials For context, older weight loss medications typically produced 58% weight loss
Additionally, I received some really great advice while I was at ISPAD 2024 from FFL Faculty Pantea Minnock